20 min listen
Episode 077: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - part 1
Episode 077: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - part 1
ratings:
Length:
20 minutes
Released:
Oct 18, 2023
Format:
Podcast episode
Description
In our last episode, we discussed our approach to primary refractory DLBCL. This week, we start our conversation about relapsed DLBCL! This is an important and complex discussion, so we have split it into two episodes to help you follow along. If you have not done so already, we recommend you check out episode 076 for a discussion about the primary refractory setting.Content: - Approach to relapsed disease (after 12 months)- How to approach relapse with CNS involvement- Role of CAR-T vs. autologous transplant in this setting- How to approach treatment in patients who are poor candidates for auto or CAR-T** This episode is sponsored by HemOnc.org** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Oct 18, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 013: Heme/Onc Emergencies, Pt. 2: Brain Mets: Ronak Mistry, Vivek Patel, Dan Hausrath by The Fellow on Call: The Heme/Onc Podcast